Cell Banking Outsourcing Market

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.

Cell Banking Outsourcing Market contains market size and forecasts of Cell Banking Outsourcing in Global, including the following market information:

Global Cell Banking Outsourcing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cell Banking Outsourcing market was valued at 7049.4 million in 2021 and is projected to reach US$ 20370 million by 2028, at a CAGR of 16.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Stem Cell Banking Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cell Banking Outsourcing include SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec and CordLife, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cell Banking Outsourcing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell Banking Outsourcing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cell Banking Outsourcing Market Segment Percentages, by Type, 2021 (%)

Stem Cell Banking

Non-stem Cell Banking

Global Cell Banking Outsourcing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cell Banking Outsourcing Market Segment Percentages, by Application, 2021 (%)

Cell Bank Storage

Bank Characterization and Testing

Cell Bank Preparation

Global Cell Banking Outsourcing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cell Banking Outsourcing Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cell Banking Outsourcing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cell Banking Outsourcing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

SGS Life Sciences

Lonza

CCBC

Vcanbio

AMAG Pharmaceuticals

ViaCord

Thermo Fisher

Wuxi Apptec

CordLife

Esperite

Reliance Life Sciences

Lifecell

Cryo-Cell

Toxikon

Goodwin Biotechnology

Texcell

Cryo Stemcell